Antifibrotic Drug Development Summit
R&D
As fibrosis stakeholders invest in bolstering their early pipeline to limit early candidate drop off, the 7th Antifibrotic Drug Development (AFDD) Summit explores actionable strategies to take this further.
AFDD has what you need to better interrogate antifibrotic potential and bridge the translational gap:
- Pioneering fibrosis quantification with more sensitive fluid and imaging biomarkers that predict, stage and diagnose fibrosis
- More confident translation to the clinic by harnessing state-of-the-art in-vitro models that truly recapitulate fibrosis
- Game-changing target ID supercharged by uncovering molecular networks, novel pathways and mapping crosstalk
With 80+ experts from early-stage research to late translational, this unique scientific forum unites industry leaders across fibrotic disease to energize your fibrosis research.
